Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA.
Public Health Rep. 2022 Jan-Feb;137(1):62-71. doi: 10.1177/0033354920988285. Epub 2021 Feb 26.
Although marijuana use has increased since 2012, the perceived risk of adverse outcomes has decreased. This systematic review summarizes articles that examined the association between nonmedical marijuana use (ie, observed smoking, self-report, or urinalysis) and cardiovascular events in observational or experimental studies of adults aged ≥18.
We searched Medline, EMBASE, PsycInfo, CINAHL, Cochrane Library Database, and Global Health from January 1, 1970, through August 31, 2018. Of 3916 citations, 16 articles fit the following criteria: (1) included adults aged ≥18; (2) included marijuana/cannabis use that is self-reported smoked, present in diagnostic coding, or indicated through a positive diagnostic test; (3) compared nonuse of cannabis; (4) examined events related to myocardial infarction, angina, acute coronary syndrome, and/or stroke; (5) published in English; and (6) had observational or experimental designs.
Of the 16 studies, 4 were cohort studies, 8 were case-control studies, 1 was a case-crossover study, 2 were randomized controlled trials, and 1 was a descriptive study. Studies ranged from 10 participants to 118 659 619 hospitalizations. Marijuana use was associated with an increased likelihood of myocardial infarction within 24 hours in 2 studies and stroke in 6 studies. Results of studies suggested an increased risk for angina and acute coronary syndrome, especially among people with a history of a cardiovascular event.
This review suggests that people who use marijuana may be at increased risk for cardiovascular events. As states expand new laws permitting marijuana use, it will be important to monitor the effect of marijuana use on cardiovascular disease outcomes, perhaps through the inclusion of data on nonmedical marijuana use in diverse national and local surveillance systems.
尽管自 2012 年以来大麻的使用有所增加,但人们对不良后果的认知风险却有所降低。本系统评价总结了在观察性或实验性研究中,对年龄≥18 岁的成年人进行非医疗大麻使用(即观察到的吸烟、自我报告或尿液分析)与心血管事件之间关联的文章。
我们从 1970 年 1 月 1 日至 2018 年 8 月 31 日,在 Medline、EMBASE、PsycInfo、CINAHL、Cochrane 图书馆数据库和全球卫生数据库中进行了搜索。在 3916 条引文,16 篇文章符合以下标准:(1)纳入年龄≥18 岁的成年人;(2)包括自我报告吸烟、诊断编码中的大麻/大麻使用或通过阳性诊断检测表明的大麻/大麻使用;(3)比较不使用大麻;(4)检测与心肌梗死、心绞痛、急性冠脉综合征和/或中风相关的事件;(5)以英文发表;(6)具有观察性或实验性设计。
在 16 项研究中,4 项为队列研究,8 项为病例对照研究,1 项为病例交叉研究,2 项为随机对照试验,1 项为描述性研究。研究范围从 10 名参与者到 118659619 例住院患者。两项研究表明,大麻使用与 24 小时内心肌梗死的可能性增加有关,六项研究表明与中风有关。研究结果表明,心绞痛和急性冠脉综合征的风险增加,尤其是在有心血管事件史的人群中。
本综述表明,使用大麻的人可能面临心血管事件的风险增加。随着各州扩大新的允许大麻使用的法律,监测大麻使用对心血管疾病结果的影响将非常重要,也许可以通过在各种国家和地方监测系统中纳入非医疗大麻使用的数据来实现。